Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT03503097Terminated
Genetic Testing for Men With Metastatic Prostate Cancer
Metastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
PrincipalinvestigatorStart date: 2017-08-21
NCT02598895Phase 2Completed
Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
PrincipalinvestigatorStart date: 2016-01-26

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaCastration Levels of TestosteroneMetastatic Prostate Carcinoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score17%

Michael Schweizer

Fred Hutch/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaStage IVB Prostate Cancer AJCC v8Castration Levels of Testosterone+3 more

Worked with same sponsors:

National Cancer Institute (NCI)University of Washington
Similarity Score13%

Jeremie Calais

UCLA / Jonsson Comprehensive Cancer Center

Related
9 trials

Shared therapeutic areas:

Metastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8Castration-Resistant Prostate Carcinoma+2 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score11%

Charles Ryan, MD

University of California, San Francisco

Related
6 trials

Shared therapeutic areas:

Castration Levels of TestosteroneProstate Carcinoma Metastatic in the BonePSA Progression+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score9%

Vassiliki Papadimitrakopoulou

SWOG Cancer Research Network

Related
9 trials

Shared therapeutic areas:

ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Robert Montgomery

Fred Hutch/University of Washington Cancer Consortium

Related
6 trials

Shared therapeutic areas:

Metastatic Prostate CarcinomaCastration-Resistant Prostate CarcinomaStage IV Prostate Cancer

Worked with same sponsors:

National Cancer Institute (NCI)University of Washington
Similarity Score6%

Sarina A Piha-Paul

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

A P Chen

National Cancer Institute LAO

Related
8 trials

Shared therapeutic areas:

Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Jeremie Calais, MD

UCLA / Jonsson Comprehensive Cancer Center

Related
5 trials

Shared therapeutic areas:

Stage IVB Prostate Cancer AJCC v8Castration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Roxana S. Dronca, MD

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Metastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03442556Phase 2PrincipalInvestigator

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

ATM Gene MutationBRCA1 Gene MutationBRCA2 Gene Mutation+7 more
Terminated
NCT03503097PrincipalInvestigator

Genetic Testing for Men With Metastatic Prostate Cancer

Metastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8
Terminated
NCT02598895Phase 2PrincipalInvestigator

Docetaxel and Carboplatin in Treating Patients With Metastatic, Castration Resistant Prostate Cancer Containing Inactivated Genes in the BRCA 1/2 Pathway

Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+3 more
Completed

All 3 trials loaded